2,2-diphenyl-benzo[1,3]dioxol-5-amine | 88145-34-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,2-diphenyl-benzo[1,3]dioxol-5-amine
• 英文别名: 2,2-Diphenyl-1,3-benzodioxol-5-amine
• CAS: 88145-34-0
• 化学式: C₁₉H₁₅NO₂
• 分子量: 289.334
• InChiKey: HTDWPDKJCFFSEL-UHFFFAOYSA-N

物化性质

• 熔点：
  115.5-116.5 °C
• 沸点：
  464.6±45.0 °C(Predicted)
• 密度：
  1.259±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2,2-diphenyl-benzo[1,3]dioxol-5-amine 在 吡啶 、 木榴油 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 2-(3,4-dihydroxy-phenylcarbamoyl)-8-hydroxyquinoline-7-carboxylic acid
  参考文献：
  名称：

  Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity

  摘要：

  A novel series of HIV-1 integrase inhibitors was synthesized and tested in both in vitro and ex vivo assays. These inhibitors are featured by the presence of a quinoline subunit and an ancillary aromatic ring linked by functionalized spacers such as amide, hydrazide, urea and 1-hydroxyprop-l-en-3-one moiety. Amide derivatives are the most promising ones and could serve as leads for further developments. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.005
• 作为产物：
  描述：

  5-Nitro-2,2-diphenyl-benzo[1,3]dioxole 在 镍 氢气 作用下， 以 乙醇 为溶剂， 以85%的产率得到2,2-diphenyl-benzo[1,3]dioxol-5-amine
  参考文献：
  名称：

  Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity

  摘要：

  A novel series of HIV-1 integrase inhibitors was synthesized and tested in both in vitro and ex vivo assays. These inhibitors are featured by the presence of a quinoline subunit and an ancillary aromatic ring linked by functionalized spacers such as amide, hydrazide, urea and 1-hydroxyprop-l-en-3-one moiety. Amide derivatives are the most promising ones and could serve as leads for further developments. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.005

文献信息

• [EN] NOVEL BENZODIOXOLES<br/>[FR] NOUVEAUX BENZODIOXOLES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2004013120A1

  公开（公告）日：2004-02-12

  The present invention relates to compound of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases, which are associated with the modulation of CB1 receptors.

  本发明涉及具有式（I）的化合物，其中R1、R2、R3、R4、R5、R6、R7和X如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与CB1受体调节相关的疾病。
• Benzodioxole derivatives
  申请人：Alanine Alexander

  公开号：US20050143373A1

  公开（公告）日：2005-06-30

  The present invention relates to compounds of the general formula and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases such as obesity by selective modulation of CB1 receptors.

  本发明涉及一般式的化合物及其药学上可接受的盐。该化合物通过选择性调节CB1受体，对于治疗和/或预防肥胖等疾病是有用的。
• HOUWING, H. A.;OENE, J. C.;HORN, A. S., PHARM. WEEKBL. SCI. ED., 1983, 5, N 4, 177-181
  作者：HOUWING, H. A.、OENE, J. C.、HORN, A. S.

  DOI：——

  日期：——
• NOVEL BENZODIOXOLES
  申请人：F.HOFFMANN-LA ROCHE AG

  公开号：EP1532132B1

  公开（公告）日：2008-03-19
• US6900227B2
  申请人：——

  公开号：US6900227B2

  公开（公告）日：2005-05-31